Human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma: a potential therapeutic target

Liang Xia,1,2,* Yang Wang,1,* Yuhua Hu,1,* Chunye Zhang,1 Ting Gu,1 Lizhen Wang,1 Jiang Li,1 Wenwen Yu,2 Zhen Tian1 1Department of Oral Pathology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People&...

Full description

Bibliographic Details
Main Authors: Xia L, Wang Y, Hu Y, Zhang C, Gu T, Wang L, Li J, Yu W, Tian Z
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/human-epithelial-growth-factor-receptor-2-in-human-salivary-carcinoma--peer-reviewed-article-CMAR
_version_ 1818956653030014976
author Xia L
Wang Y
Hu Y
Zhang C
Gu T
Wang L
Li J
Yu W
Tian Z
author_facet Xia L
Wang Y
Hu Y
Zhang C
Gu T
Wang L
Li J
Yu W
Tian Z
author_sort Xia L
collection DOAJ
description Liang Xia,1,2,* Yang Wang,1,* Yuhua Hu,1,* Chunye Zhang,1 Ting Gu,1 Lizhen Wang,1 Jiang Li,1 Wenwen Yu,2 Zhen Tian1 1Department of Oral Pathology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China; 2Department of Oral and Cranio-maxillofacial Surgery, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China *These authors contributed equally to this work Background: To inhibit human epithelial growth factor receptor 2 (HER2) in salivary carcinoma ex pleomorphic adenoma (CXPA) and investigate the effects on tumor cell proliferation, cell cycle, and apoptosis. To assess the possibility of blocking HER2 to improve the malignant biological behavior of CXPA. Materials and methods: HER2 expression and amplification were examined using an immunofluorescence assay and fluorescence in situ hybridization in 2 CXPA cell lines (SM-AP1 and SM-AP4 cells). The effects on tumor cell proliferation, cell cycle, apoptosis, and HER2 downstream pathways were verified after the application of a HER2 inhibitor. Results: HER2 was overexpressed and amplified in SM-AP1 and SM-AP4 cell lines. After blocking HER2, the tumor proliferation and cell cycle were significantly induced, and the apoptosis process was activated. Moreover, the downstream pathways PI3K/AKT and MAPK/ERK were significantly inhibited. Conclusion: HER2 was overexpressed and amplified in CXPA cell lines and might thus play an important role in tumor development. Inhibiting HER2 may be a novel targeted therapy for poor biological behavior of CXPA. Keywords: HER2, amplification, carcinoma ex pleomorphic adenoma, proliferation, apoptosis, target therapy
first_indexed 2024-12-20T10:57:22Z
format Article
id doaj.art-9e5239197be242f992112e7767f8f287
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-20T10:57:22Z
publishDate 2018-11-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-9e5239197be242f992112e7767f8f2872022-12-21T19:43:07ZengDove Medical PressCancer Management and Research1179-13222018-11-01Volume 106571657942739Human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma: a potential therapeutic targetXia LWang YHu YZhang CGu TWang LLi JYu WTian ZLiang Xia,1,2,* Yang Wang,1,* Yuhua Hu,1,* Chunye Zhang,1 Ting Gu,1 Lizhen Wang,1 Jiang Li,1 Wenwen Yu,2 Zhen Tian1 1Department of Oral Pathology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China; 2Department of Oral and Cranio-maxillofacial Surgery, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Key Laboratory of Stomatology, Shanghai 200011, People’s Republic of China *These authors contributed equally to this work Background: To inhibit human epithelial growth factor receptor 2 (HER2) in salivary carcinoma ex pleomorphic adenoma (CXPA) and investigate the effects on tumor cell proliferation, cell cycle, and apoptosis. To assess the possibility of blocking HER2 to improve the malignant biological behavior of CXPA. Materials and methods: HER2 expression and amplification were examined using an immunofluorescence assay and fluorescence in situ hybridization in 2 CXPA cell lines (SM-AP1 and SM-AP4 cells). The effects on tumor cell proliferation, cell cycle, apoptosis, and HER2 downstream pathways were verified after the application of a HER2 inhibitor. Results: HER2 was overexpressed and amplified in SM-AP1 and SM-AP4 cell lines. After blocking HER2, the tumor proliferation and cell cycle were significantly induced, and the apoptosis process was activated. Moreover, the downstream pathways PI3K/AKT and MAPK/ERK were significantly inhibited. Conclusion: HER2 was overexpressed and amplified in CXPA cell lines and might thus play an important role in tumor development. Inhibiting HER2 may be a novel targeted therapy for poor biological behavior of CXPA. Keywords: HER2, amplification, carcinoma ex pleomorphic adenoma, proliferation, apoptosis, target therapyhttps://www.dovepress.com/human-epithelial-growth-factor-receptor-2-in-human-salivary-carcinoma--peer-reviewed-article-CMARHER2AmplificationCarcinoma ex pleomorphic adenomaProliferationApoptosisTarget therapy
spellingShingle Xia L
Wang Y
Hu Y
Zhang C
Gu T
Wang L
Li J
Yu W
Tian Z
Human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma: a potential therapeutic target
Cancer Management and Research
HER2
Amplification
Carcinoma ex pleomorphic adenoma
Proliferation
Apoptosis
Target therapy
title Human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma: a potential therapeutic target
title_full Human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma: a potential therapeutic target
title_fullStr Human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma: a potential therapeutic target
title_full_unstemmed Human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma: a potential therapeutic target
title_short Human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma: a potential therapeutic target
title_sort human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma a potential therapeutic target
topic HER2
Amplification
Carcinoma ex pleomorphic adenoma
Proliferation
Apoptosis
Target therapy
url https://www.dovepress.com/human-epithelial-growth-factor-receptor-2-in-human-salivary-carcinoma--peer-reviewed-article-CMAR
work_keys_str_mv AT xial humanepithelialgrowthfactorreceptor2inhumansalivarycarcinomaexpleomorphicadenomaapotentialtherapeutictarget
AT wangy humanepithelialgrowthfactorreceptor2inhumansalivarycarcinomaexpleomorphicadenomaapotentialtherapeutictarget
AT huy humanepithelialgrowthfactorreceptor2inhumansalivarycarcinomaexpleomorphicadenomaapotentialtherapeutictarget
AT zhangc humanepithelialgrowthfactorreceptor2inhumansalivarycarcinomaexpleomorphicadenomaapotentialtherapeutictarget
AT gut humanepithelialgrowthfactorreceptor2inhumansalivarycarcinomaexpleomorphicadenomaapotentialtherapeutictarget
AT wangl humanepithelialgrowthfactorreceptor2inhumansalivarycarcinomaexpleomorphicadenomaapotentialtherapeutictarget
AT lij humanepithelialgrowthfactorreceptor2inhumansalivarycarcinomaexpleomorphicadenomaapotentialtherapeutictarget
AT yuw humanepithelialgrowthfactorreceptor2inhumansalivarycarcinomaexpleomorphicadenomaapotentialtherapeutictarget
AT tianz humanepithelialgrowthfactorreceptor2inhumansalivarycarcinomaexpleomorphicadenomaapotentialtherapeutictarget